Merck (NYSE:MRK) recently presented promising results from the Phase 3 ZENITH trial for its drug WINREVAIR, but the company's stock performance over the past month tells a different story, declining ...
Citi analyst Geoff Meacham maintained a Buy rating on Merck & Company (MRK – Research Report) today. The company’s shares closed last ...
Alphabet, Oracle, ServiceNow, Salesforce, Merck & Co., Inc., UnitedHealth Group, and Vertiv are the seven Healthcare stocks ...
Merck (MRK) announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR compared to placebo in adults with ...
The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . Shareholders who purchased shares of MRK ...
SCHD's 2025 reconstitution aligns with market shifts, boosting Energy and Consumer Staples. Discover insights on dividend ...
This article summarizes the top insider buys and sells for US stocks reported on Friday, March 28, 2025. Top Insider Buys: ...
Major indices turned in a mixed performance on Monday as market participants patiently awaited clarity on Donald Trump's ...
Stay informed with our latest analysis on Dow Jones Industrial Average stocks to watch today. Get real-time market insights ...
NCAA March Madness is upon us. You're not opening one of my articles to read about college basketball, instead, I'll run you ...
France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the billionaire Bettencourt-Meyers family ...
Discover which stocks are splitting, the ratio, and split ex-date with the latest information from EDGAR® Online LLC. Data provided by and © 2024 EDGAR® Online LLC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback